Please wait

As filed with the Securities and Exchange Commission on October 20, 2015

Registration No. 333-            

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

WebMD Health Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   20-2783228

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

111 Eighth Avenue

New York, New York 10011

(Address, Including Zip Code, of Principal Executive Offices)

 

 

WebMD Health Corp.

Amended and Restated 2005 Long-Term Incentive Plan

(Full Title of the Plan)

 

 

Douglas W. Wamsley

Executive Vice President, General Counsel and Secretary

WebMD Health Corp.

111 Eighth Avenue

New York, New York 10011

(212) 624-3700

(Name, Address and Telephone Number, Including Area Code, of Agent for Service)

 

 

Copies to:

Doreen E. Lilienfeld

Shearman & Sterling LLP

599 Lexington Avenue

New York, New York 10022

Tel: (212) 848-4000

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   þ    Accelerated filer   ¨
Non-accelerated filer   ¨      Smaller reporting company   ¨

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of

Securities To Be Registered

 

Amount

To Be

Registered(1)

 

Proposed Maximum

Offering Price

Per Share(2)

 

Proposed

Maximum

Aggregate

Offering Price(2)

 

Amount of

Registration

Fee(2)

Common Stock, par value $0.01 per share

  1,700,000   $43.32   $73,644,000.00   $7,415.95

 

 

 

(1) 

This registration statement on Form S-8 (this “Registration Statement”) registers an aggregate of 1,700,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”) of WebMD Health Corp., a Delaware corporation (the “Company” or the “Registrant”) available for issuance pursuant to the WebMD Health Corp. Amended and Restated 2005 Long-Term Incentive Plan (the “Plan”). Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of Common Stock that become issuable under the Plan as a result of adjustments under the Plan by reason of one or more stock splits, stock dividends or similar transactions.

(2) 

Pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended (the “Securities Act”), the Proposed Maximum Offering Price Per Share and the Proposed Maximum Offering Price are based on the average of the high and low prices of the Registrant’s Common Stock reported on the Nasdaq National Market on October 15, 2015 and are estimated solely for the purpose of calculating the registration fee.

 

 

 


STATEMENT PURSUANT TO GENERAL INSTRUCTION E

TO FORM S-8

The contents of the Registration Statement on Form S-8 (File No. 333-162653) relating to the Plan, filed with the Securities and Exchange Commission (the “Commission”) on October 23, 2009 are hereby incorporated by reference.

 

2


SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Form S-8 Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on October 20, 2015.

 

WEBMD HEALTH CORP.
By:   /s/ Peter Anevski
  Peter Anevski
  Executive Vice President &
Chief Financial Officer

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints each of Peter Anevski, Lewis H. Leicher and Douglas W. Wamsley as such person’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead, in any and all capacities, to sign any and all amendments to the Registration Statement, including post-effective amendments, and registration statements filed pursuant to Rule 462 under the Securities Act, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, and does hereby grant unto each said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that each said attorney-in-fact and agent, or any substitute therefor, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

/s/ David J. Schlanger

   Chief Executive Officer   October 20, 2015

David J. Schlanger

   (principal executive officer)  

/s/ Peter Anevski

   Executive Vice President & Chief   October 20, 2015

Peter Anevski

   Financial Officer (principal financial and
accounting officer)
 

/s/ Mark J. Adler, M.D.

   Director   October 20, 2015

Mark J. Adler, M.D.

    

 

3


/s/ Kevin M. Cameron

   Director   October 20, 2015

Kevin M. Cameron

    

/s/ Neil F. Dimick

   Director  

October 20, 2015

Neil F. Dimick

    

/s/ Jerome C. Keller

   Director  

October 20, 2015

Jerome C. Keller

    
     Director  

James V. Manning

    

/s/ William J. Marino

   Director  

October 20, 2015

William J. Marino

    

/s/ Joseph E. Smith

   Director  

October 20, 2015

Joseph E. Smith

    

/s/ Stanley S. Trotman, Jr.

   Director  

October 20, 2015

Stanley S. Trotman, Jr.

    

/s/ Kristiina Vuori, M.D.

   Director  

October 20, 2015

Kristiina Vuori, M.D.

    

/s/ Martin J. Wygod

   Director  

October 20, 2015

Martin J. Wygod

    

 

4


EXHIBIT INDEX

 

Exhibit No.

    

Description

  3.1           Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Registration Statement on Form S-8 filed on October 23, 2009 (Reg. No. 333-162651))
  3.2           Amended and Restated By-laws of the Registrant (incorporated by reference to Exhibit 3.2 to the Registrant’s Registration Statement on Form S-8 filed on October 23, 2009 (Reg. No. 333-162651))
  4.1           WebMD Health Corp. Amended and Restated 2005 Long-Term Incentive Plan, as amended effective October 1, 2015 (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed on October 2, 2015)
  5.1           Opinion of Lewis H. Leicher, Esq., Senior Vice President & Assistant General Counsel of the Registrant, as to the legality of the securities registered hereby*
  23.1           Consent of Ernst & Young LLP, independent registered public accounting firm for the Registrant*
  23.2           Consent of Counsel (included in Exhibit 5.1)*
  24.1           Power of Attorney (included in this Registration Statement under “Signatures”).*

 

 

* Filed herewith.

 

E-1